HOME >> MEDICINE >> NEWS
Stem-cell research hints at better looking cosmetic and reconstructive surgery

Stem-cell researchers have shown how cosmetic surgery, such as wrinkle removal and breast augmentation, might be improved with natural implants that keep their original size and shape better than synthetics.

Cosmetic surgery might be performed with stem-cell generated natural tissues instead of synthetic implants. Saline and silicone implants for breast augmentation may rupture, leak, and interfere with breast cancer detection on mammograms. Stem-cell generated natural tissue implants should avoid these problems.

Reconstructive surgery to replace tissues lost to cancer or other disease could benefit from stem-cell generated natural implants that do not shrink or lose their shape. Studies have shown that conventional soft-tissue implants can lose 40 percent to 60 percent of their volume over time. Examples are breast tissue reconstruction after breast cancer surgery and facial soft-tissue reconstruction following cancer or trauma surgeries.

Natural implants often require separate surgical procedures from a healthy location of the patient's body to obtain tissue for constructing the implant. The stem-cell approach does not require extensive surgery because cells needed for the implant are obtained in a less invasive needle procedure.

Whitaker investigator Jeremy Mao, Ph.D., of the University of Illinois at Chicago presented his results at the annual meeting of the American Association for the Advancement of Science in Washington, D.C., saying that a stem-cell approach might eliminate the need for the additional surgery and may produce a long-lasting, shapely, and natural implant. The research will be published in April in the journal Tissue Engineering.

Mao's research group started with a line of human stem cells taken from the bone marrow of a healthy, young volunteer. These mesenchymal stem cells can transform themselves into many different cell types under appropriate conditions, including those that form cartilage, bone,
'"/>

Contact: Frank Blanchard
frank@whitaker.org
703-528-2430
Whitaker Foundation
17-Feb-2005


Page: 1 2 3

Related medicine news :

1. Public morally obliged to take part in scientific research, says leading ethicist
2. U of M researcher says Viagra may cause permanent vision loss in some men
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. RIT takes eye-tracking research to next level
6. UW research shows risk factors for relapse among health care professionals who abuse drugs
7. Protein that helps skin cancer spread identified by Stanford researchers
8. US life expectancy about to decline, researchers say
9. Ethical discussion should come before research
10. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
11. Gene for age-related macular degeneration discovered by Yale researchers

Post Your Comments:
(Date:5/20/2013)... (PRWEB) May 20, 2013 This summer, ... the world will make the pilgrimage to San Diego, ... annual Digital Health Summer Summit produced by ... a unique forum to showcase the latest digital health ... practices, and network with some of industry’s most brilliant ...
(Date:5/20/2013)... May 20, 2013 For more than ... waged a battle against drug and alcohol abuse around ... released its first guide to help Italian speakers reverse ... by the European Monitoring Centre for Drugs and Drug ... have used cannabis in the last year. As a ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... What is it about toothpaste that transforms the sweet ... the solution to that mysterious sensory phenomenon in ... the American Chemical Society,s award-winning Bytesize Science ... from the world,s largest scientific society, explains that the ... lauryl sulfate, or SLS for short. When you brush ...
(Date:5/20/2013)... MAYWOOD, Il. - Nearly three out of ... disorders during their pregnancies, a Loyola University Medical Center ... only minimal impacts on pregnant women,s quality of life, ... Scott Graziano, MD and Payton Johnson was presented during ... Clinical Meeting in New Orleans. , One hundred and ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/19/2013)... ORLANDO, Fla. , May 19, 2013 /PRNewswire/ ... power and low temperature radiofrequency (RF) energy is ... and eliminates or reduces the need for medication ... long-term assessment presented today at the Digestive Disease ... Orlando, Florida . ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
Cached News: